Trial Details
Not RecruitingBasic Information
| Clinical ID | c5120 |
|---|---|
| Identifier | EUCTR2010-023947-14-ES |
| Trial Title | Prospective, Randomized and Comparative Study to evaluate the efficacy of two vaccines against Hepatitis B virus in inflammatory bowel disease patients - COMVI-B Proyect |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Prophylaxis against Hepatitis B virus MedDRA version: 14.0.Level: LLT.Classification code 10019743.Term: Hepatitis B virus (HBV).System Organ Class: 10022891 - Investigations.;Therapeutic area: Diseases [C] - Di |
| Interventions | Trade Name: ENGERIX-B 20mg / 1ml suspensn inyectable en jeringa precargadaProduct Name: FENDRIXProduct Code: Not ApplicablePharmaceutical Form: Solution for injectionINN or Proposed INN: ANTIGENO SUPERFICIE HEPATITIS BOther descrip |
Participant Information
| Sponsor | Hospital Universitario La Princesa |
|---|---|
| City | NULL |
| Country/Region | Spain |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |